NCT00175643View on ClinicalTrials.gov

Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

November 30, 2005

Conditions
Actinic Keratoses
Interventions
DRUG

imiquimod

Trial Locations (1)

V5Z 4E8

Clinical Trials Unit, Skin Care Centre, UBC Dermatology, Vancouver

All Listed Sponsors
collaborator

Vancouver Coastal Health Research Institute

OTHER

collaborator

3M

INDUSTRY

lead

University of British Columbia

OTHER

NCT00175643 - Safety and Efficacy of Imiquimod Applied in Dose-Cycle for Actinic Keratoses | Biotech Hunter | Biotech Hunter